Skip to main content
Top
Published in: Annals of Surgical Oncology 9/2014

01-09-2014 | Hepatobiliary Tumors

Effect of Body Composition on Outcomes after Hepatic Resection for Hepatocellular Carcinoma

Authors: Shinji Itoh, MD, PhD, Ken Shirabe, MD, PhD, FACS, Yoshihiro Matsumoto, MD, Shohei Yoshiya, MD, Jun Muto, MD, Norifumi Harimoto, MD, PhD, Yo-ichi Yamashita, MD, PhD, Toru Ikegami, MD, PhD, FACS, Tomoharu Yoshizumi, MD, FACS, Akihiro Nishie, MD, PhD, Yoshihiko Maehara, MD, PhD, FACS

Published in: Annals of Surgical Oncology | Issue 9/2014

Login to get access

Abstract

Purpose

To evaluate the effect of body composition on outcomes after hepatic resection for patients with hepatocellular carcinoma (HCC).

Methods

We performed 190 hepatic resections for HCC and divided the patients into 2 groups on the basis of visceral fat area (VFA), assessed by computed tomographic measurement at the level of the umbilicus, into high VFA (H-VFA) (n = 106) and low VFA (L-VFA) (n = 84) groups. We compared the surgical outcomes between the two groups.

Results

L-VFA was significantly correlated with a lower body mass index, sarcopenia, lower serum albumin, and liver cirrhosis. There was no difference in the incidence of postoperative complications and mortality between the 2 groups. Patients in the L-VFA group had a significantly poorer prognosis than those in the H-VFA group in terms of both overall (P = 0.043) and recurrence-free (P = 0.001) survival. The results of multivariate analysis showed that sarcopenia rather than L-VFA was an independent and prognostic indicator after hepatic resection with HCC.

Conclusions

Body composition is an important factor affecting cancer outcomes after hepatic resection for HCC in Japan.
Literature
1.
go back to reference Bruix J, Lovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519–24.PubMedCrossRef Bruix J, Lovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519–24.PubMedCrossRef
2.
go back to reference Bosch FX, Ribes J, Díaz M, et al. Primary liver cancer: worldwide incidence and trends (review). Gastroenterology. 2004;127:S5–16.PubMedCrossRef Bosch FX, Ribes J, Díaz M, et al. Primary liver cancer: worldwide incidence and trends (review). Gastroenterology. 2004;127:S5–16.PubMedCrossRef
3.
go back to reference Takenaka K, Kawahara N, Yamamoto K, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg. 1996;131:71–6.PubMedCrossRef Takenaka K, Kawahara N, Yamamoto K, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg. 1996;131:71–6.PubMedCrossRef
4.
go back to reference Shirabe K, Takeishi K, Taketomi A, et al. Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era. World J Surg. 2011;35:1072–84.PubMedCrossRef Shirabe K, Takeishi K, Taketomi A, et al. Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era. World J Surg. 2011;35:1072–84.PubMedCrossRef
5.
go back to reference Itoh S, Morita K, Ueda S, et al. Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas. Ann Surg Oncol. 2009;16:3299–307.PubMedCrossRef Itoh S, Morita K, Ueda S, et al. Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas. Ann Surg Oncol. 2009;16:3299–307.PubMedCrossRef
6.
go back to reference Yamashita Y-i, Taketomi A, Itoh S, et al. Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma. J Am Coll Surg. 2007;205:19–26. Yamashita Y-i, Taketomi A, Itoh S, et al. Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma. J Am Coll Surg. 2007;205:19–26.
7.
go back to reference Itoh S, Fukuzawa K, Shitomi Y, et al. Impact of the VIO system in hepatic resection for patients with hepatocellular carcinoma. Surg Today. 2012;42:1176–82.PubMedCrossRef Itoh S, Fukuzawa K, Shitomi Y, et al. Impact of the VIO system in hepatic resection for patients with hepatocellular carcinoma. Surg Today. 2012;42:1176–82.PubMedCrossRef
8.
go back to reference Uchiyama H, Itoh S, Higashi T, et al. A two-step hanging maneuver for a complete resection of Couinaud’s segment I. Dig Surg. 2012;29:202–5.PubMedCrossRef Uchiyama H, Itoh S, Higashi T, et al. A two-step hanging maneuver for a complete resection of Couinaud’s segment I. Dig Surg. 2012;29:202–5.PubMedCrossRef
9.
go back to reference Taketomi A, Kitagawa D, Itoh S, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg. 2007;204:580–7.PubMedCrossRef Taketomi A, Kitagawa D, Itoh S, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg. 2007;204:580–7.PubMedCrossRef
10.
go back to reference Itoh S, Shirabe K, Taketomi A, et al. Zero mortality in more than 300 hepatic resections: validity of preoperative volumetric analysis. Surg Today. 2012;42:435–40.PubMedCrossRef Itoh S, Shirabe K, Taketomi A, et al. Zero mortality in more than 300 hepatic resections: validity of preoperative volumetric analysis. Surg Today. 2012;42:435–40.PubMedCrossRef
11.
go back to reference Merkow RP, Bilimoria KY, McCarter MD, et al. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg. 2009;208:53–61.PubMedCrossRef Merkow RP, Bilimoria KY, McCarter MD, et al. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg. 2009;208:53–61.PubMedCrossRef
12.
go back to reference Mullen JT, Davenport DL, Hutter MM, et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol. 2007;15:2164–72.CrossRef Mullen JT, Davenport DL, Hutter MM, et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol. 2007;15:2164–72.CrossRef
13.
go back to reference Itoh S, Ikeda Y, Kawanaka H, et al. The effect of overweight status on the short-term and 20-y outcomes after hepatic resection in patients with hepatocellular carcinoma. J Surg Res. 2012;178:640–5.PubMedCrossRef Itoh S, Ikeda Y, Kawanaka H, et al. The effect of overweight status on the short-term and 20-y outcomes after hepatic resection in patients with hepatocellular carcinoma. J Surg Res. 2012;178:640–5.PubMedCrossRef
14.
go back to reference Sugisawa N, Tokunaga M, Tanizawa Y, et al. Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat. Gastric Cancer. 2012;15:206–12.PubMedCrossRef Sugisawa N, Tokunaga M, Tanizawa Y, et al. Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat. Gastric Cancer. 2012;15:206–12.PubMedCrossRef
15.
go back to reference Cecchini S, Cavazzini E, Marchesi F, et al. Computed tomography volumetric fat parameters versus body mass index for predicting short-term outcomes of colon surgery. World J Surg. 2011;35:415–23.PubMedCrossRef Cecchini S, Cavazzini E, Marchesi F, et al. Computed tomography volumetric fat parameters versus body mass index for predicting short-term outcomes of colon surgery. World J Surg. 2011;35:415–23.PubMedCrossRef
16.
go back to reference Harimoto N, Shirabe K, Yamashita YI, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100:1523–30.PubMedCrossRef Harimoto N, Shirabe K, Yamashita YI, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100:1523–30.PubMedCrossRef
17.
go back to reference Kvist H, Chowdhury B, Sjöström L, et al. Adipose tissue volume determination in males by computed tomography and 40 K. Int J Obes. 1988;12:249–66.PubMed Kvist H, Chowdhury B, Sjöström L, et al. Adipose tissue volume determination in males by computed tomography and 40 K. Int J Obes. 1988;12:249–66.PubMed
18.
go back to reference Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999;211:283–6.PubMedCrossRef Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999;211:283–6.PubMedCrossRef
19.
go back to reference Pringle JH. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg. 1908;48:58–62.CrossRef Pringle JH. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg. 1908;48:58–62.CrossRef
20.
go back to reference Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complication: five-year experience. Ann Surg. 2009;250:187–96.PubMedCrossRef Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complication: five-year experience. Ann Surg. 2009;250:187–96.PubMedCrossRef
21.
go back to reference World Health Organization. Obesity: preventing and managing the global epidemic. Geneva, Switzerland: World Health Organization; 2000. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva, Switzerland: World Health Organization; 2000.
22.
go back to reference Kashihara H, Lee JS, Kawakubo K, et al. Criteria of waist circumference according to computed tomography-measured visceral fat area and the clustering of cardiovascular risk factors. Circ J. 2009;73:1881–6.PubMedCrossRef Kashihara H, Lee JS, Kawakubo K, et al. Criteria of waist circumference according to computed tomography-measured visceral fat area and the clustering of cardiovascular risk factors. Circ J. 2009;73:1881–6.PubMedCrossRef
23.
go back to reference Mano Y, Shirabe K, Yamashita Y, et al. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 2013;258:301–5.PubMedCrossRef Mano Y, Shirabe K, Yamashita Y, et al. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 2013;258:301–5.PubMedCrossRef
24.
go back to reference Shirabe K, Itoh S, Yoshizumi T, et al. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma—with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol. 2007;95:235–40.PubMedCrossRef Shirabe K, Itoh S, Yoshizumi T, et al. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma—with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol. 2007;95:235–40.PubMedCrossRef
25.
go back to reference Itoh S, Maeda T, Shimada M, et al. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res. 2004;10:2812–7.PubMedCrossRef Itoh S, Maeda T, Shimada M, et al. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res. 2004;10:2812–7.PubMedCrossRef
26.
go back to reference Takeishi K, Taketomi A, Shirabe K, et al. Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway. J Hepatol. 2012;57:77–83.PubMedCrossRef Takeishi K, Taketomi A, Shirabe K, et al. Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway. J Hepatol. 2012;57:77–83.PubMedCrossRef
27.
go back to reference Gaujoux S, Torres J, Olson S, et al. Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg Oncol. 2012;19:2908–16.PubMedCrossRef Gaujoux S, Torres J, Olson S, et al. Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg Oncol. 2012;19:2908–16.PubMedCrossRef
28.
go back to reference Saunders JK, Rosman AS, Neihaus D, et al. Safety of hepatic resections in obese veterans. Arch Surg. 2012;147:331–7.PubMedCrossRef Saunders JK, Rosman AS, Neihaus D, et al. Safety of hepatic resections in obese veterans. Arch Surg. 2012;147:331–7.PubMedCrossRef
29.
30.
go back to reference van Vledder MG, Levolger S, Ayez N, et al. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99:550–7.PubMedCrossRef van Vledder MG, Levolger S, Ayez N, et al. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99:550–7.PubMedCrossRef
32.
go back to reference Sacks GS, Dearman K, Replogle WH, et al. Use of subjective global assessment to identify nutrition-associated complications and death in geriatric long-term care facility residents. J Am Coll Nutr. 2000;19:570–577.PubMedCrossRef Sacks GS, Dearman K, Replogle WH, et al. Use of subjective global assessment to identify nutrition-associated complications and death in geriatric long-term care facility residents. J Am Coll Nutr. 2000;19:570–577.PubMedCrossRef
33.
go back to reference Pausch T, Hartwig W, Hinz U, et al. Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer. Surgery. 2012;152(3 Suppl 1):S81–8.PubMedCrossRef Pausch T, Hartwig W, Hinz U, et al. Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer. Surgery. 2012;152(3 Suppl 1):S81–8.PubMedCrossRef
34.
go back to reference Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12:433–450. Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12:433–450.
35.
Metadata
Title
Effect of Body Composition on Outcomes after Hepatic Resection for Hepatocellular Carcinoma
Authors
Shinji Itoh, MD, PhD
Ken Shirabe, MD, PhD, FACS
Yoshihiro Matsumoto, MD
Shohei Yoshiya, MD
Jun Muto, MD
Norifumi Harimoto, MD, PhD
Yo-ichi Yamashita, MD, PhD
Toru Ikegami, MD, PhD, FACS
Tomoharu Yoshizumi, MD, FACS
Akihiro Nishie, MD, PhD
Yoshihiko Maehara, MD, PhD, FACS
Publication date
01-09-2014
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 9/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3686-6

Other articles of this Issue 9/2014

Annals of Surgical Oncology 9/2014 Go to the issue

Pancreatic Tumors

More Harm than Good?